PEPFAR Technical Guidance in Context of COVID-19 Pandemic
The evidence on the impact of COVID-19 amongst People Living with HIV (PLHIV) is still scarce. There is currently no direct evidence that PLHIV are at higher risk of COVID-19. As more data becomes available from regions of high prevalence, PEPFAR has indicated that they will continue to provide updates on the effect of COVID-19 on PLHIV. HIV virological suppression is a critical intervention that improves the health of all PLHIV, and PEPFAR stated that they are committed to ensuring that PLHIV have uninterrupted care. This document provides guiding principles for the provision of HIV-related services in PEPFAR-supported countries during the COVID- 19 Pandemic.